LITRACEN
UNII 2B3D399IVR

Substance Identification & Data

This profile provides standardized clinical and technical data for Litracen, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 2B3D399IVR.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 5118-30-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

2B3D399IVR

CAS Registry Number

5118-30-9

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

LITRACEN

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C20H23N

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

AUZMDLDJTGPIEA-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C66022

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

82730

Unique identification number in the NCBI database of chemical substances.

INN ID

1572

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

c1cccc2C(c3ccccc3C(c21)=CCCNC)(C)C

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Litracen. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.